Our Core Product, the TruePhysio® pressure microcatheter and VivoCardio® FFR system, is the first and only domestically developed FFR system approved in China, as well as the first MEMS-sensor rapid-exchange FFR system worldwide. Our FFR system, which is a precision intravascular physiology solution, enables physicians to perform precision diagnosis of functional ischemia in coronary heart diseases.
In March 2021, we have launched FFR-cRR, our Core Product with cRR feature, in Europe based on our innovative constant Resistance Ratio (cRR) technology, which enables physiological assessment without vasodilators and saves operation time and costs.
Our FFR system can be used in a broader set of clinical applications as we continue to improve the diagnosis of coronary artery diseases.
Zone E, 3rd Floor, Building 3,
Tinwe Business Park, No. 6 Liufang Rd.
Baoan District, Shenzhen, P.R. China, 518101.